SOURCE: ONE Bio, Corp.

March 16, 2010 08:30 ET

ONE Bio to Sponsor Major Health Product Tradeshow in New Jersey

MIAMI, FL--(Marketwire - March 16, 2010) -  ONE Bio, Corp. ("ONE" or the "Company") (OTCBB: ONBI), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced that its subsidiary, Green Planet Bioengineering Co., Ltd. ("GP"), the Company's health supplements and raw extracts division, has agreed to sponsor and exhibit at the SupplySide East, one of the largest US health product tradeshows. The sponsorship is part of an overall strategy to expand distribution for the Company's products in Asia, Europe and the United States.

The SupplySide East show is an informative, educational and connecting event that gathers thousands of health product suppliers, manufacturers and pharmaceutical leaders from all over the world to meet, start and build relationships. In addition, the show provides networking tools and opportunities prior to show date to Sponsors like ONE and exhibitors.

"We are very excited to sponsor and exhibit at the SupplySide East show. This is a great opportunity for our health supplements and raw extracts subsidiary, Green Planet, to expand its international footprint," stated Min Zhao, President (China). "We have already initiated discussions with various distributors attending the show," added Zhao.

"Our team is working hard to break ground in various markets including the US. We are seeing an increase in the consumption of organic and health products and we intend to take advantage of it," stated ONE's CEO Marius Silvasan. "Our growth strategy is based on continued organic growth coupled with strategic acquisitions of high margin/high profit companies in the organic products and natural and health supplements segments," added Silvasan.

ONE/Green Planet's booth number is 1451 and the Company will be hosting a Happy Hour on April 26th from 4-5pm where it will exhibit several of its products.

About ONE Bio, Corp.
ONE Bio, Corp. ("ONE") (OTCBB: ONBI) (, headquartered in Miami, FL, is an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on capitalizing on the rapidly growing markets of the Asia Pacific region. Key products include widely recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. ONE's growth plan targets an aggressive acquisition driven strategy supported by strong organic growth. Through ONE, small private companies gain access to capital, experienced management and strategic insight. ONE builds strong synergies amongst all subsidiaries to enhance shareholder value. ONE is working with each subsidiary to promote organic and acquisition driven growth.

About SupplySide East
SupplySide East is an event where thousands of executives from the food, supplement and cosmetic industries connect with key suppliers of innovative ingredients and technologies. This business-to-business event is open to ingredient suppliers, manufacturing service providers, manufacturers/marketers of consumer packaged goods, industry professionals and qualified media personnel. This is not a consumer event and is not open to the general public.

This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE Bio, Corp. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. These risks and other factors are detailed in the Company's regular filings with the U.S. Securities and Exchange Commission. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and ONE Bio, Corp. does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact Information

  • Contact:

    Company and Investor Relations
    Jeanne Chan
    Senior VP
    Tel. +877.544.2288

    Investor Relations & Corporate Communications